That's the part of the company I have been focusing on, the supposed database. My argument about the MYDX data forever has been the non-lab conditions and questioning users strictly adhering to the guidelines in sampling (changing chamber, cartridge, etc).
I still can't believe a company like Pfizer, who PROFITED $52b last year, would risk billions on some random database. Doesn't make sense, especially with the extremely high likelihood big Pharma has plenty of data in a controlled lab environment to support their lobbying efforts to squash medical marijuana.